Glockzin, Gabriel and Piso, Pompiliu (2012) Current Status and Future Directions in Gastric Cancer with Peritoneal Dissemination. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 21 (4). 625-+. ISSN 1055-3207, 1558-5042
Full text not available from this repository. (Request a copy)Abstract
Peritoneal carcinomatosis arising from gastric cancer is mostly associated with poor prognosis. Despite the improvement of survival with modern polychemotherapy, the results are still unsatisfactory. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy might provide an additional therapeutic option for highly selected patients with gastric cancer and peritoneal metastasis leading to improved prognosis. Considering the increased rate of perioperative morbidity and the crucial prognostic role of complete macroscopic cytoreduction, adequate preoperative diagnostics and patient selection are strongly recommended. Further prospective randomized trials are needed to determine the roles of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as part of an interdisciplinary treatment concept.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY; ADVANCED ESOPHAGOGASTRIC CANCER; CYTOREDUCTIVE SURGERY; SURFACE MALIGNANCY; SUPPORTIVE CARE; CARCINOMATOSIS; FLUOROURACIL; PLUS; METHOTREXATE; MORTALITY; Peritoneal carcinomatosis; Gastric cancer; Treatment; Cytoreductive surgery; HIPEC |
Subjects: | 600 Technology > 610 Medical sciences Medicine |
Divisions: | Medicine > Lehrstuhl für Chirurgie |
Depositing User: | Dr. Gernot Deinzer |
Date Deposited: | 05 May 2020 05:46 |
Last Modified: | 05 May 2020 05:46 |
URI: | https://pred.uni-regensburg.de/id/eprint/18010 |
Actions (login required)
View Item |